Lund, Sweden

Susanna Moller

This inventor holds 1 USPTO granted patent. Top assignee: Bioinvent International Ab. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susanna Moller. Retrieved from https://idiyas.com/inventor/susanna-moller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 389(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susanna Moller: Innovator in Monoclonal Antibody Production

Introduction

Susanna Moller is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of immunology, particularly in the production of human monoclonal antibodies. Her innovative methods have the potential to advance medical research and therapeutic applications.

Latest Patents

Susanna Moller holds a patent for a method of producing human monoclonal antibodies and a kit for this purpose. The patent describes a method for the removal of undesired cells from human lymphocyte-containing cell populations using lysosomotropic agents. This technique is crucial for in vitro immunization, allowing for the effective production of human monoclonal antibodies. The kit includes active constituents such as lymphokines and lysosomotropic agents, facilitating the immunization process.

Career Highlights

Moller is associated with Bioinvent International AB, where she continues to work on innovative solutions in the field of biotechnology. Her research focuses on enhancing the efficiency of monoclonal antibody production, which is vital for various therapeutic applications.

Collaborations

Some of her notable coworkers include Carl A Borrebaeck and Lena Danielsson. Their collaborative efforts contribute to the advancement of research in immunology and biotechnology.

Conclusion

Susanna Moller is a key figure in the development of methods for producing human monoclonal antibodies. Her work at Bioinvent International AB and her innovative patent highlight her contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…